Education
About Us
Working with TipRanks
Follow Us
Seres Therapeutics (DE:1S90)
FRANKFURT:1S90
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 789.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 144.93M |
| Gross Profit | $ 0.00 | $ -3.53M | $ 0.00 | $ 0.00 | $ 144.93M |
| Operating Income | $ -93.97M | $ -121.31M | $ -195.10M | $ -179.91M | $ -64.49M |
| EBITDA | $ -93.97M | $ -120.30M | $ -181.42M | $ -170.93M | $ -56.72M |
| Net Income | $ 5.70M | $ 136.00K | $ -113.72M | $ -250.16M | $ -65.58M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 45.77M | $ 30.79M | $ 127.97M | $ 181.34M | $ 290.71M |
| Total Assets | $ 138.19M | $ 139.81M | $ 358.60M | $ 348.78M | $ 354.86M |
| Total Debt | $ 82.97M | $ 91.64M | $ 198.78M | $ 162.59M | $ 49.21M |
| Net Debt | $ 37.20M | $ 60.85M | $ 70.82M | $ -440.00K | $ -130.79M |
| Total Liabilities | $ 93.97M | $ 126.03M | $ 403.46M | $ 338.00M | $ 223.35M |
| Stockholders' Equity | $ 44.22M | $ 13.78M | $ -44.86M | $ 10.78M | $ 131.51M |
| Cash Flow | |||||
| Free Cash Flow | $ 865.00K | $ -148.99M | $ -125.33M | $ -238.64M | $ -2.88M |
| Operating Cash Flow | $ 1.12M | $ -148.61M | $ -117.35M | $ -228.82M | $ 6.69M |
| Investing Cash Flow | $ -42.00K | $ 142.29M | $ 10.58M | $ 82.43M | $ 64.09M |
| Financing Cash Flow | $ 13.90M | $ -90.37M | $ 71.70M | $ 129.60M | $ 1.18M |